skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Blood remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)
Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

Hughes, Timothy P. ; Hochhaus, Andreas ; Branford, Susan ; Müller, Martin C. ; Kaeda, Jaspal S. ; Foroni, Letizia ; Druker, Brian J. ; Guilhot, François ; Larson, Richard A. ; O'Brien, Stephen G. ; Rudoltz, Marc S. ; Mone, Manisha ; Wehrle, Elisabeth ; Modur, Vijay ; Goldman, John M. ; Radich, Jerald P.

Blood, 2010-11, Vol.116 (19), p.3758-3765 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias

Walker, Christopher J. ; Oaks, Joshua J. ; Santhanam, Ramasamy ; Neviani, Paolo ; Harb, Jason G. ; Ferenchak, Gregory ; Ellis, Justin J. ; Landesman, Yosef ; Eisfeld, Ann-Kathrin ; Gabrail, Nash Y. ; Smith, Carrie L. ; Caligiuri, Michael A. ; Hokland, Peter ; Roy, Denis Claude ; Reid, Alistair ; Milojkovic, Dragana ; Goldman, John M. ; Apperley, Jane ; Garzon, Ramiro ; Marcucci, Guido ; Shacham, Sharon ; Kauffman, Michael G. ; Perrotti, Danilo

Blood, 2013-10, Vol.122 (17), p.3034-3044 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies

Oaks, Joshua J. ; Santhanam, Ramasamy ; Walker, Christopher J. ; Roof, Steve ; Harb, Jason G. ; Ferenchak, Greg ; Eisfeld, Ann-Kathrin ; Van Brocklyn, James R. ; Briesewitz, Roger ; Saddoughi, Sahar A. ; Nagata, Kyosuke ; Bittman, Robert ; Caligiuri, Michael A. ; Abdel-Wahab, Omar ; Levine, Ross ; Arlinghaus, Ralph B. ; Quintas-Cardama, Alfonso ; Goldman, John M. ; Apperley, Jane ; Reid, Alistair ; Milojkovic, Dragana ; Ziolo, Mark T. ; Marcucci, Guido ; Ogretmen, Besim ; Neviani, Paolo ; Perrotti, Danilo

Blood, 2013-09, Vol.122 (11), p.1923-1934 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias

Ottmann, Oliver G. ; Druker, Brian J. ; Sawyers, Charles L. ; Goldman, John M. ; Reiffers, Jose ; Silver, Richard T. ; Tura, Sante ; Fischer, Thomas ; Deininger, Michael W. ; Schiffer, Charles A. ; Baccarani, Michele ; Gratwohl, Alois ; Hochhaus, Andreas ; Hoelzer, Dieter ; Fernandes-Reese, Sofia ; Gathmann, Insa ; Capdeville, Renaud ; O'Brien, Stephen G.

Blood, 2002-09, Vol.100 (6), p.1965-1971 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999
Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999

Peters, Charles ; Charnas, Lawrence R. ; Tan, Ye ; Ziegler, Richard S. ; Shapiro, Elsa G. ; DeFor, Todd ; Grewal, Satkiran S. ; Orchard, Paul J. ; Abel, Susan L. ; Goldman, Anne I. ; Ramsay, Norma K.C. ; Dusenbery, Kathryn E. ; Loes, Daniel J. ; Lockman, Lawrence A. ; Kato, Shunichi ; Aubourg, Patrick R. ; Moser, Hugo W. ; Krivit, William

Blood, 2004-08, Vol.104 (3), p.881-888 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

Sawyers, Charles L. ; Hochhaus, Andreas ; Feldman, Eric ; Goldman, John M. ; Miller, Carole B. ; Ottmann, Oliver G. ; Schiffer, Charles A. ; Talpaz, Moshe ; Guilhot, Francois ; Deininger, Michael W.N. ; Fischer, Thomas ; O'Brien, Steve G. ; Stone, Richard M. ; Gambacorti-Passerini, Carlo B. ; Russell, Nigel H. ; Reiffers, Jose J. ; Shea, Thomas C. ; Chapuis, Bernard ; Coutre, Steven ; Tura, Sante ; Morra, Enrica ; Larson, Richard A. ; Saven, Alan ; Peschel, Christian ; Gratwohl, Alois ; Mandelli, Franco ; Ben-Am, Monique ; Gathmann, Insa ; Capdeville, Renaud ; Paquette, Ronald L. ; Druker, Brian J.

Blood, 2002-05, Vol.99 (10), p.3530-3539 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
7
European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor
European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor
Material Type:
Artigo 		Adicionar ao Meu Espaço

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor

Marin, David ; Milojkovic, Dragana ; Olavarria, Eduardo ; Khorashad, Jamshid S. ; de Lavallade, Hugues ; Reid, Alistair G. ; Foroni, Letizia ; Rezvani, Katayoun ; Bua, Marco ; Dazzi, Francesco ; Pavlu, Jiri ; Klammer, Matthias ; Kaeda, Jaspal S. ; Goldman, John M. ; Apperley, Jane F.

Blood, 2008-12, Vol.112 (12), p.4437-4444 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC

Cuvelier, Geoffrey D.E. ; Logan, Brent R. ; Prockop, Susan E. ; Buckley, Rebecca H. ; Kuo, Caroline Y. ; Griffith, Linda M. ; Liu, Xuerong ; Yip, Alison ; Hershfield, Michael S. ; Ayoub, Paul G. ; Moore, Theodore B. ; Dorsey, Morna J. ; O'Reilly, Richard J. ; Kapoor, Neena ; Pai, Sung-Yun ; Kapadia, Malika ; Ebens, Christen L. ; Forbes Satter, Lisa R. ; Burroughs, Lauri M. ; Petrovic, Aleksandra ; Chellapandian, Deepak ; Heimall, Jennifer ; Shyr, David C. ; Rayes, Ahmad ; Bednarski, Jeffrey J. ; Chandra, Sharat ; Chandrakasan, Shanmuganathan ; Gillio, Alfred P. ; Madden, Lisa ; Quigg, Troy C. ; Caywood, Emi H. ; Dávila Saldaña, Blachy J. ; DeSantes, Kenneth ; Eissa, Hesham ; Goldman, Frederick D. ; Rozmus, Jacob ; Shah, Ami J. ; Vander Lugt, Mark T. ; Thakar, Monica S. ; Parrott, Roberta E. ; Martinez, Caridad ; Leiding, Jennifer W. ; Torgerson, Troy R. ; Pulsipher, Michael A. ; Notarangelo, Luigi D. ; Cowan, Morton J. ; Dvorak, Christopher C. ; Haddad, Elie ; Puck, Jennifer M. ; Kohn, Donald B.

Blood, 2022-08, Vol.140 (7), p.685-705 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

Talpaz, Moshe ; Silver, Richard T. ; Druker, Brian J. ; Goldman, John M. ; Gambacorti-Passerini, Carlo ; Guilhot, Francois ; Schiffer, Charles A. ; Fischer, Thomas ; Deininger, Michael W.N. ; Lennard, Anne L. ; Hochhaus, Andreas ; Ottmann, Oliver G. ; Gratwohl, Alois ; Baccarani, Michele ; Stone, Richard ; Tura, Sante ; Mahon, Francois-Xavier ; Fernandes-Reese, Sofia ; Gathmann, Insa ; Capdeville, Renaud ; Kantarjian, Hagop M. ; Sawyers, Charles L.

Blood, 2002-03, Vol.99 (6), p.1928-1937 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Larson, Richard A. ; Druker, Brian J. ; Guilhot, Francois ; O'Brien, Stephen G. ; Riviere, Gilles J. ; Krahnke, Tillmann ; Gathmann, Insa ; Wang, Yanfeng

Blood, 2008-04, Vol.111 (8), p.4022-4028 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.